Problem
Health data is fragmented between hospitals, UBS, laboratories, municipalities, SUS systems, and private operators. This lack of interoperability makes it difficult to access patient records, generates rework, duplication of tests, delays in diagnoses, and increased operating costs. It also impairs continuity of care and managers' ability to make decisions based on data. The startup solves this problem by creating an integration layer that connects different systems and transforms dispersed data into a unified and actionable history.
Solution
The platform works as an interoperability layer for the health ecosystem. Through RESTful APIs, microservices, and the HL7 FHIR standard, it connects legacy systems and different sources, including e-SUS, private ERPs, hospitals, UBS, laboratories, and health plans. The solution synchronizes data, unifies the patient's electronic record, and automates the routing of exam results. Thus, managers and professionals access more complete information, while citizens, laboratories, and institutions reduce rework, paperwork, and unnecessary repetition of exams.
Business model
The model combines B2B and B2G SaaS. Municipalities and health plans pay a recurring subscription calculated according to the size of the population served or the number of active lives. Laboratories pay a small fee per transaction for automated report routing. The integration for UBS and direct access for citizens can be offered free of charge to accelerate adoption and expand the network. There may also be recipes for deployment, integration, customization, training, and support. The average ticket is still being validated and will be defined according to population, volume of transactions, number of integrations, and level of service.
Market
The startup operates in the global digital health market, interoperability, data integration, electronic records, and health information analysis. The initial focus is on Brazil, especially city halls, health departments, hospitals, UBS, laboratories, and regional plans. However, data fragmentation and the need for interoperability are problems present in public and private systems in several countries. The use of APIs, microservices and the HL7 FHIR standard allows the solution to be adapted to different regulatory and technological ecosystems.
Competitors
Competitors include official SUS management systems and platforms, such as e-SUS APS, SUS Digital Manager, and SIAPS, in addition to electronic records, hospital ERPs, laboratory systems, and private health interoperability solutions. Spreadsheets, integrations developed internally, and manual reporting processes are also current alternatives. The startup's differential is to connect, in a single layer, public and private data, allowing communication between municipalities, UBS, hospitals, laboratories and health plans.
Competitive differentiation
The difference lies in offering a neutral layer of integration between different organizations and health systems, without requiring the immediate replacement of the platforms already used. The solution combines RESTful APIs, HL7 FHIR standard, data synchronization, unified medical records, and automated result routing. In addition to serving public managers, it connects hospitals, public health centers, laboratories, health plans and citizens, creating an integrated source of information. The platform is also designed to operate with security, adherence to the LGPD, role-based access control, and scalable architecture.
Entry barrier
The main barrier to entry will be formed by the technical and operational complexity of the integrations with public and private systems, the accumulated knowledge about health flows, and the network of partners connected to the platform. Each new implementation generates integration models, data mappings, business rules, and indicators adapted to the local reality. As the network grows, so do platform effects: the more municipalities, hospitals, laboratories, and plans that participate, the greater the value of the solution and the more difficult it will be to replicate the ecosystem.